Differences in All-Cause Mortality Among Transgender and Non-Transgender People Enrolled in Private Insurance
- PMID: 35548863
- PMCID: PMC9195044
- DOI: 10.1215/00703370-9942002
Differences in All-Cause Mortality Among Transgender and Non-Transgender People Enrolled in Private Insurance
Abstract
Few studies have analyzed mortality rates among transgender (trans) populations in the United States and compared them to the rates of non-trans populations. Using private insurance data from 2011 to 2019, we estimated age-specific all-cause mortality rates among a subset of trans people enrolled in private insurance and compared them to a 10% randomly selected non-trans cohort. Overall, we found that trans people were nearly twice as likely to die over the period as their non-trans counterparts. When stratifying by gender, we found key disparities within trans populations, with people on the trans feminine to nonbinary spectrum being at the greatest risk of mortality compared to non-trans males and females. While we found that people on the trans masculine to nonbinary spectrum were at a similar risk of overall mortality compared to non-trans females, their overall mortality rate was statistically smaller than that of non-trans males. These findings provide evidence that some trans and non-trans populations experience substantially different mortality conditions across the life course and necessitate further study.
Keywords: Disparity; Gender; Life expectancy; Mortality; Transgender.
Copyright © 2022 The Authors.
Figures



Similar articles
-
US Black-White Differences in Mortality Risk Among Transgender and Cisgender People in Private Insurance, 2011-2019.Am J Public Health. 2022 Oct;112(10):1507-1514. doi: 10.2105/AJPH.2022.306963. Epub 2022 Aug 18. Am J Public Health. 2022. PMID: 35981277 Free PMC article.
-
Privately Insured Transgender People Are At Elevated Risk For Chronic Conditions Compared With Cisgender Counterparts.Health Aff (Millwood). 2021 Sep;40(9):1440-1448. doi: 10.1377/hlthaff.2021.00546. Health Aff (Millwood). 2021. PMID: 34519545 Free PMC article.
-
Leveraging Administrative Claims to Understand Disparities in Gender Minority Health: Contraceptive Use Patterns Among Transgender and Nonbinary People.LGBT Health. 2022 Apr;9(3):186-193. doi: 10.1089/lgbt.2021.0303. Epub 2022 Mar 17. LGBT Health. 2022. PMID: 35297673
-
Barriers and Challenges in Caring for Transgender People: Implications for Clinical Practice and the Experience From a Specialized Center.J Dr Nurs Pract. 2023 Mar 1;16(1):44-53. doi: 10.1891/JDNP-2021-0022. J Dr Nurs Pract. 2023. PMID: 36918281 Review.
-
Cardiovascular Health of Youth During Gender-Affirming Testosterone Treatment: A Review.J Adolesc Health. 2021 Dec;69(6):896-904. doi: 10.1016/j.jadohealth.2021.08.009. Epub 2021 Oct 7. J Adolesc Health. 2021. PMID: 34627656 Review.
Cited by
-
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer.Nat Rev Urol. 2023 Jun;20(6):332-355. doi: 10.1038/s41585-023-00778-3. Epub 2023 May 22. Nat Rev Urol. 2023. PMID: 37217695 Free PMC article. Review.
-
Frailty Among Sexual and Gender Minority Older Adults: The All of Us Database.J Gerontol A Biol Sci Med Sci. 2023 Oct 28;78(11):2111-2118. doi: 10.1093/gerona/glad149. J Gerontol A Biol Sci Med Sci. 2023. PMID: 37485864 Free PMC article.
-
Research Considerations in Digestive and Liver Disease in Transgender and Gender-Diverse Populations.Gastroenterology. 2023 Sep;165(3):523-528.e1. doi: 10.1053/j.gastro.2023.07.011. Gastroenterology. 2023. PMID: 37599011 Free PMC article. No abstract available.
-
Analysis of Mortality Among Transgender and Gender Diverse Adults in England.JAMA Netw Open. 2023 Jan 3;6(1):e2253687. doi: 10.1001/jamanetworkopen.2022.53687. JAMA Netw Open. 2023. PMID: 36716027 Free PMC article.
-
Doing Justice: Ethical Considerations Identifying and Researching Transgender and Gender Diverse People in Insurance Claims Data.J Med Syst. 2024 Oct 12;48(1):96. doi: 10.1007/s10916-024-02111-w. J Med Syst. 2024. PMID: 39394534 Free PMC article.
References
-
- Ashley F (forthcoming). ‘Trans’ is my gender modality: A modest terminological proposal. In Laura Erickson-Schroth (Ed.), Trans bodies, trans selves (2nd ed.). New York, NY: Oxford University Press. https://www.florenceashley.com/uploads/1/2/4/4/124439164/florence_ashley...
-
- Asscheman H, Giltay EJ, Megens JAJ, de Ronde W, van Trotsenburg MAA, & Gooren LJG (2011). A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology, 164, 635–642. - PubMed
-
- Balzer C (2020). Trans murder monitoring (2008–Sept 2020): Trans respect vs transphobia worldwide (Figure). Retrieved from https://transrespect.org/en/map/trans-murder-monitoring/
-
- Becasen JS, Denard CL, Mullins MM, Higa DH, & Sipe TA (2019). Estimating the prevalence of HIV and sexual behaviors among the U.S. transgender population: A systematic review and meta-analysis, 2006–2017. American Journal of Public Health, 109(1), e1–e8. 10.2105/AJPH.2018.304727 - DOI - PMC - PubMed
-
- Bennett GG, Merritt MM, Sollers JJ III, Edwards CL, Whitfield KE, Brandon DT, & Tucker RD (2004). Stress, coping, and health outcomes among African-Americans: A review of the John Henryism hypothesis. Psychology & Health, 19, 369–383.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources